23 related articles for article (PubMed ID: 10502041)
1. Apoptotic markers for primary brain tumor prognosis.
Konstantinidou AE; Korkolopoulou P; Patsouris E
J Neurooncol; 2005 Apr; 72(2):151-6. PubMed ID: 15925995
[TBL] [Abstract][Full Text] [Related]
2. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH
J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.
Frankel B; Longo SL; Leach C; Canute GW; Ryken TC
J Neurooncol; 2002 Aug; 59(1):27-34. PubMed ID: 12222835
[TBL] [Abstract][Full Text] [Related]
4. Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.
Frankel B; Longo SL; Canute GW
J Neurooncol; 2000 May; 48(1):21-6. PubMed ID: 11026693
[TBL] [Abstract][Full Text] [Related]
5. FasL expression on epithelial cells: the Bottazzo-Feldman hypothesis revisited.
Dayan CM; Elsegood KA; Maile R
Immunol Today; 1997 May; 18(5):203. PubMed ID: 9153948
[No Abstract] [Full Text] [Related]
6. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.
Frankel B; Longo SL; Ryken TC
J Neurooncol; 1999; 44(3):205-12. PubMed ID: 10720200
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas.
Strege RJ; Godt C; Stark AM; Hugo HH; Mehdorn HM
J Neurooncol; 2004; 67(1-2):29-39. PubMed ID: 15072445
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
[TBL] [Abstract][Full Text] [Related]
9. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
Deininger MH; Weller M; Streffer J; Meyermann R
Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.
Gratas C; Tohma Y; Van Meir EG; Klein M; Tenan M; Ishii N; Tachibana O; Kleihues P; Ohgaki H
Brain Pathol; 1997 Jul; 7(3):863-9. PubMed ID: 9217971
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors.
Frankel B; Longo SL; Ryken TC
Acta Neuropathol; 1999 Oct; 98(4):363-6. PubMed ID: 10502041
[TBL] [Abstract][Full Text] [Related]
12. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]